CXCL10 and neoplasm: Namely, epigenetic reprogramming of chemokine expression has been reported upon treatment with DNMTi, EZH2i and LSD1, increasing tumor production of CXCL9 and CXCL10 chemokines (103, 104), known to be involved in T cell recruitment to the tumor.